Cancer care to the population of Russia in 2022

Author:

Shakhzadova A. O.1ORCID,Starinsky V. V.1ORCID,Lisichnikova I. V.1ORCID

Affiliation:

1. P.A. Hertsen Moscow oncology Research institute – Branch of the National Medical Research Radiological Centre of the Ministryof Health of Russia

Abstract

Objective: to analyze cancer statistics in Russia as a whole, as well as in individual regions of the Russian Federation.Material and Methods. Based on data from the state medical statistics according to the form No. 7 “information on malignant neoplasms for 2022” the crude and standardized rates, standard error of crude and standardized rates, confidence intervals (ci) for 2022, and the qualitative parameters of cancer care were calculated.Results. in 2022, 624,835 new cancer cases were detected in the Russian Federation (283,179 in men and 341,656 in women), in increase of 7.6 % compared to 2021 (in 2021: 580415), and decrease of 2.4 % compared to 2019 (in 2019: 640391). in 2022, the crude incidence rate was 425.89 ± 0.54 per 100,000 population of Russia (ci: 424.83–426.95 per 100,000 population), which was 7.0 % higher than that in 2021 (in 2021 – 397.91 ± 0.54 per 100,000 population) but 2.4 % lower than in 2019 (in 2019 – 436.34 ± 0.52 per 100,000 population). the standardized incidence rate was 236.47 ± 0.32 per 100,000 population (ci: 235.84–237.10 per 100,000 population), which was 5.2 % higher compared to that observed in 2021 (in 2021 – 224.87 ± 0.32 per 100,000 population) but 5.2 % lower than in 2019 (in 2019 – 249.54 ± 0.33 per 100,000 population). the prevalence rate of cancer in 2022 was 2,742.4 per 100,000 population of Russia, an increase in the prevalence rate over 10 years was 33.9 %.Conclusion. Сancer care in the Russian Federation in 2022 was provided at the proper level. there is a positive trend in the early detection of cancer, which partly influences the reduction in the one-year mortality rate.

Publisher

Tomsk Cancer Research Institute

Subject

Cancer Research,Oncology

Reference6 articles.

1. Petrova G.V., Gretsova O.P., Starinsky V.V., Kharchenko N.V., Merabishvili V.M. Characteristics and methods for calculating statistical parameters used in oncology. Moscow, 2005. 39 p. (in Russian).

2. Malignant tumors in Russia in 2019 (morbidity and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, A.O. Shahzadova. Moscow, 2020. 252 p. (in Russian).

3. Malignant tumors in Russia in 2021 (morbidity and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow, 2022. 252 p. (in Russian).

4. Zhuikova L.D., Choynzonov E.L., Ananina O.A., Pikalova L.V., Kononova G.A. The prevalence of oncological diseases among the population of the Siberia region and the Far East. Health care of the Russian Federation. 2023; 67(1): 64–71. (in Russian). doi: 10.47470/0044-197X-2023-67-1-64-71.

5. Merabishvili V.M. Malignant neoplasms in Northwestern Federal District of Russia (incidence, mortality, survival). St. Petersburg, 2023. 296 p. (in Russian).

Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3